Enterprise Value to EBITDA Ratio: Sera Prognostics Inc. (SERA)

seraprognostics.com (SERA) - corporate logo

Sera Prognostics is expanding its medical presence through partnerships with clinics and insurers to improve prenatal monitoring. This EV/EBITDA price chart, with a value of 0.00, illustrates the current business valuation. Cash flows will become regular as the insurance sector recognizes the technology. The company's prospects rely on the implementation of high-precision proteomic tests to predict preterm birth.

Sera Prognostics - SERA Total Company Value to Operating Income Before Depreciation Ratio (period 11/23/2025 - 11/10/2026)

Sera Prognostics Inc. - analytical breakdowns and key metrics (SERA)

- current price and projected stock value:
Stock Price Sera Prognostics, Inc.|SERA - Consensus Target
- company stock exchange capitalization indicators:
Market Valuation Sera Prognostics, Inc.|SERA - Aggregate Business Value
- business book valuation details:
Book Value per Share Sera Prognostics|SERA - Book Valuation of Business|Market Value to Book Value Ratio seraprognostics.com|SERA - Company Assets
- debt obligations and liquidity statistics:
Debt to Equity Sera Prognostics|SERA - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Sera Prognostics|SERA - Company Total Debt Obligations|Debts to Book Capitalization Sera Prognostics, Inc.|SERA - Long-Term Debt|Company Short-Term Debt Sera Prognostics|Quick Ratio seraprognostics.com
- financial results and valuation multiples details:
SERA - Net Profit|Future Profit Sera Prognostics|SERA - Company Value to Net Income|Future Price to Earnings Sera Prognostics, Inc.|SERA - Market Cap to Earnings and Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sera Prognostics, Inc.|SERA - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Sera Prognostics|SERA - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth seraprognostics.com|SERA - Net earnings per share change in current year|Net earnings per share growth forecast for next year Sera Prognostics
Comprehensive company analysis:Sera Prognostics, Inc. SERA
Original product of Sera Prognostics

For Sera Prognostics (SERA), business valuation relative to operating profit is critical amid sanction pressures on prenatal diagnostics. By analyzing changes in the company's EV/EBITDA ratio, investors compare market capitalization with debt and actual cash flow before taxes. An increase in this metric signals asset overvaluation or a decline in profitability due to logistical disruptions, while a stable trend confirms the model's resilience to geopolitical risks.

Competitor analysis

EV/EBITDA Multiple NTRA (Natera Corp)|HUMA - Enterprise Value to EBITDA Ratio